Ingles Markets declares quarterly cash dividend
ASHEVILLE, N.C. — Ingles Markets announced that its board of directors has declared a quarterly cash dividend of 16.5 cents per share on all its class A common stock and 15 cents per share on all its class B common stock. This is an annual rate of 66 cents and 60 cents, respectively.
Both dividends are payable Oct. 25 to shareholders of record on Oct. 11.
Kaiser Health News: Legislation to be introduced to create new FDA office overseeing mobile health apps
MENLO PARK, Calif. — Rep. Mike Honda, D-Calif., of the Silicon Valley is preparing to introduce legislation that will create a new division within the Food and Drug Administration to govern fast-developing healthcare applications, according to a report published by Kaiser Health News last week.
It’s big business — according to projections made by Research2guidance, the healthcare mobile app market, dubbed mHealth, could total $1.3 billion by year’s end, up from $718 million in 2011.
Honda’s legislation, called the Healthcare Innovation and Marketplace Technologies Act, would establish a special Office of Mobile Health at the FDA to provide recommendations on mobile health app issues. The legislation would also seek the writing of a mobile health developer support program at the Department of Health and Human Services that could help app developers from violating HIPAA or other privacy regulations.
"Currently, our healthcare system works against small-to-large startup entrepreneurs with a multitude of barriers to entry," noted Honda in a statement published by Kaiser Health News. “Why have the principles of Silicon Valley, which I represent — competition, innovation and entrepreneurship — not fully manifested themselves in the healthcare information technology space? This bill gets us closer to that space.”
For the full Kaiser Health News article, click here.
Reckitt Benckiser taps Pfizer Consumer vet to lead U.S. consumer marketing
PARSIPPANY, N.J. — Reckitt Benckiser recently named Tiffany McLaud to the position of consumer healthcare marketing director. McLaud joins RB from Pfizer Consumer Healthcare where she held a number of senior positions, most recently as senior director of U.S. dietary supplements.
As RB’s healthcare marketing director, McLaud will oversee the company’s healthcare portfolio, including Mucinex, Delsym and Cepacol.
McLaud joined Pfizer in 1998 after the completion of her master’s degree in corporate and organizational communications. She had worked her way through the ranks including tenures as director of marketing, Centrum Ultra; director of U.S. marketing new products — analgesics and respiratory; and group product director of Chapstick.